Whitehall-Robins challenging Children's Tylenol ad claiming ibuprofen irritation.
This article was originally published in The Tan Sheet
Executive Summary
McNEIL CHILDREN's TYLENOL IBUPROFEN STOMACH IRRITATION TV AD will be re-aired "within a week" of Whitehall-Robins' Nov. 25 challenge of the pediatric acetaminophen ads with the three major television networks, McNeil Consumer Products said Nov. 26. McNeil responded to allegations by Children's Advil maker Whitehall-Robins that the current Children's Tylenol television ad "attempts to distort the safety profile of Children's Advil." McNeil said it is "discussing the scientific issues with the networks," but did not indicate whether the ad will be changed before the anticipated rebroadcast.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning